| Current Price | $0.86 | Mkt Cap | $350.0M |
|---|---|---|---|
| Open | $0.86 | P/E Ratio | -6.65 |
| Prev. Close | $0.86 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.83 - $0.87 | Volume | 1,305,762 |
| 52-Wk Range | $0.65 - $2.23 | Avg. Daily Vol. | 1,670,724 |
The Company is engaged in the research, development and commercialization of novel drugs for the treatment of central nervous system disorders.
| Current Price | $0.86 | Mkt Cap | $350.0M |
|---|---|---|---|
| Open | $0.86 | P/E Ratio | -6.65 |
| Prev. Close | $0.86 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $0.83 - $0.87 | Volume | 1,305,762 |
| 52-Wk Range | $0.65 - $2.23 | Avg. Daily Vol. | 1,670,724 |
The best Bull and Bear pitches based on recency and number of recommendations.
FDA approval for fish oil? What else is going on here, are they selling the good parts of the company for what?
Read the most recent pitches from players about AMRN.
Recs
TL22
(< 20)
Submitted: 10/24/2019 3:02:44 AM :
Start Price:
$16.34
NASDAQ:AMRN Score:
-147.77
The excellent results of the REDUCE-IT study cannot be overlooked. Sales of Vascepa continue to increase as more Doctors become aware of its benefits. FDA - based on the the REDUCE-IT results, a study which the FDA approved the criteria for - will (little to no doubt) allow an expanded label for Vascepa use towards the end of this year. This will result in an immediate increase in share price, which will continue to increase along with the sale of Vascepa.
Recs
XMFRendezvous
(91.68)
Submitted: 3/4/2019 4:19:13 PM :
Start Price:
$21.51
NASDAQ:AMRN Score:
-160.74
Buy the (buyout) rumor, sell the news.
High upside.. medium-high risk.
Recs
rick16
(< 20)
Submitted: 2/22/2019 4:04:09 PM :
Start Price:
$19.33
NASDAQ:AMRN Score:
-159.61
Great product...no where to go but up.... possible buyout?
Find the members with the highest scoring picks in AMRN.
vin2066 (96.89) Score: +929.25
The Score Leader is the player with the highest score across all their picks in AMRN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| Smog79 | 23.45 | 6/16/2010 |
|
3W | $2.58 | -67.60% | +311.00% | +378.60 | 0 Comment | |
| MaxPwr273 | 71.26 | 10/26/2011 |
|
5Y | $9.33 | -91.04% | +270.59% | +361.63 | 0 Comment | |
| HedgeFund007 | 24.79 | 12/6/2010 |
|
1Y | $5.50 | -84.80% | +275.28% | +360.08 | 0 Comment | |
| Okcfirefighter | < 20 | 12/17/2010 |
|
5Y | $6.72 | -87.56% | +270.08% | +357.65 | 0 Comment | |
| H8CAGERS | < 20 | 12/1/2011 |
|
1Y | $7.31 | -88.56% | +268.51% | +357.08 | 0 Comment | |
| Luisaespinoza7 | 33.52 | 5/18/2012 |
|
3M | $10.34 | -91.92% | +250.31% | +342.22 | 0 Comment | |
| smoaky | 91.97 | 3/28/2007 |
|
5Y | $21.80 | -96.17% | +243.17% | +339.34 | 0 Comment | |
| seanchile | 34.87 | 4/1/2010 |
|
3Y | $1.50 | -44.31% | +292.03% | +336.34 | 0 Comment | |
| bwlink100 | < 20 | 4/13/2007 |
|
1Y | $29.60 | -97.18% | +235.81% | +332.98 | 0 Comment | |
| DividendKings | < 20 | 2/23/2012 |
|
3W | $8.72 | -90.41% | +238.48% | +328.90 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
